Comparación de la retención del fármaco de los inhibidores de TNF, otros biológicos y inhibidores JAK en pacientes con AR que descontinuaron una terapia con inhibidor JAK
Rheumatology (Oxford) 2022 doi: 10.1093/rheumatology/keac285
Real-world population-based study shows that a switch to a second JAKinib results in a higher drug retention, as compared to switching to a TNFi, in patients with RA who discontinue original JAKinib therapy.